BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 26538324)

  • 1. Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.
    Diémé B; Mavel S; Blasco H; Tripi G; Bonnet-Brilhault F; Malvy J; Bocca C; Andres CR; Nadal-Desbarats L; Emond P
    J Proteome Res; 2015 Dec; 14(12):5273-82. PubMed ID: 26538324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of metabolic pathway disturbances using multimodal metabolomics in autistic disorders in a Middle Eastern population.
    Bitar T; Mavel S; Emond P; Nadal-Desbarats L; Lefèvre A; Mattar H; Soufia M; Blasco H; Vourc'h P; Hleihel W; Andres CR
    J Pharm Biomed Anal; 2018 Apr; 152():57-65. PubMed ID: 29414019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of gender-related metabolic disturbances in autism spectrum disorders using urinary metabolomics.
    Xiong X; Liu D; He W; Sheng X; Zhou W; Xie D; Liang H; Zeng T; Li T; Wang Y
    Int J Biochem Cell Biol; 2019 Oct; 115():105594. PubMed ID: 31449876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study.
    Rangel-Huerta OD; Gomez-Fernández A; de la Torre-Aguilar MJ; Gil A; Perez-Navero JL; Flores-Rojas K; Martín-Borreguero P; Gil-Campos M
    Metabolomics; 2019 Jun; 15(7):99. PubMed ID: 31250215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders.
    Nadal-Desbarats L; Aïdoud N; Emond P; Blasco H; Filipiak I; Sarda P; Bonnet-Brilhault F; Mavel S; Andres CR
    Analyst; 2014 Jul; 139(13):3460-8. PubMed ID: 24841505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.
    Mavel S; Nadal-Desbarats L; Blasco H; Bonnet-Brilhault F; Barthélémy C; Montigny F; Sarda P; Laumonnier F; Vourc'h P; Andres CR; Emond P
    Talanta; 2013 Sep; 114():95-102. PubMed ID: 23953447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
    Gevi F; Zolla L; Gabriele S; Persico AM
    Mol Autism; 2016; 7():47. PubMed ID: 27904735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GC-MS-based urine metabolic profiling of autism spectrum disorders.
    Emond P; Mavel S; Aïdoud N; Nadal-Desbarats L; Montigny F; Bonnet-Brilhault F; Barthélémy C; Merten M; Sarda P; Laumonnier F; Vourc'h P; Blasco H; Andres CR
    Anal Bioanal Chem; 2013 Jun; 405(15):5291-300. PubMed ID: 23571465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary
    Lussu M; Noto A; Masili A; Rinaldi AC; Dessì A; De Angelis M; De Giacomo A; Fanos V; Atzori L; Francavilla R
    Autism Res; 2017 Jun; 10(6):1058-1066. PubMed ID: 28296209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Metabonomic Profiling Discriminates Between Children with Autism and Their Healthy Siblings.
    Liang Y; Xiao Z; Ke X; Yao P; Chen Y; Lin L; Lu J
    Med Sci Monit; 2020 Nov; 26():e926634. PubMed ID: 33237888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.
    Mussap M; Noto A; Fanos V
    Expert Rev Mol Diagn; 2016 Aug; 16(8):869-81. PubMed ID: 27310602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of urinary metabolomic profiling for unstable angina pectoris disease based on nuclear magnetic resonance spectroscopy.
    Li Z; Liu X; Wang J; Gao J; Guo S; Gao K; Man H; Wang Y; Chen J; Wang W
    Mol Biosyst; 2015 Dec; 11(12):3387-96. PubMed ID: 26471262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
    Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
    J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls.
    Cozzolino R; De Magistris L; Saggese P; Stocchero M; Martignetti A; Di Stasio M; Malorni A; Marotta R; Boscaino F; Malorni L
    Anal Bioanal Chem; 2014 Jul; 406(19):4649-62. PubMed ID: 24828982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses.
    Thévenot EA; Roux A; Xu Y; Ezan E; Junot C
    J Proteome Res; 2015 Aug; 14(8):3322-35. PubMed ID: 26088811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.
    West PR; Amaral DG; Bais P; Smith AM; Egnash LA; Ross ME; Palmer JA; Fontaine BR; Conard KR; Corbett BA; Cezar GG; Donley EL; Burrier RE
    PLoS One; 2014; 9(11):e112445. PubMed ID: 25380056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.